健民集团谈净利润下降：中药材价格上涨带来的采购成本增加

财经网10-21

10月21日下午，健民集团举办2024年第三季度业绩说明会。会上有投资者询问，医药工业营收同比下降及毛利率下降是否为未来一段时间的趋势。对此，健民集团财务总监程朝阳回复表示，2024年前三季度，公司实现营业收入28.81亿元，同比下降7.58%，实现归属于上市公司股东的净利润3.22亿元，同比下降22.53%。公司营业收入分为医药工业和医药商业，前三季度公司医药商业收入保持增长，医药工业收入下降，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2477500406?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-10-21 14:06","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2477500406","market":"sh","top_or_hot":-1,"title":"健民集团谈净利润下降：中药材价格上涨带来的采购成本增加","media":"财经网","content":"<div>\n<p>10月21日下午，健民集团举办2024年第三季度业绩说明会。会上有投资者询问，医药工业营收同比下降及毛利率下降是否为未来一段时间的趋势。对此，健民集团财务总监程朝阳回复表示，2024年前三季度，公司实现营业收入28.81亿元，同比下降7.58%，实现归属于上市公司股东的净利润3.22亿元，同比下降22.53%。公司营业收入分为医药工业和医药商业，前三季度公司医药商业收入保持增长，医药工业收入下降，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021140820a1e229fa&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>健民集团谈净利润下降：中药材价格上涨带来的采购成本增加</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n健民集团谈净利润下降：中药材价格上涨带来的采购成本增加\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-21 14:06 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021140820a1e229fa&s=b><strong>财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>10月21日下午，健民集团举办2024年第三季度业绩说明会。会上有投资者询问，医药工业营收同比下降及毛利率下降是否为未来一段时间的趋势。对此，健民集团财务总监程朝阳回复表示，2024年前三季度，公司实现营业收入28.81亿元，同比下降7.58%，实现归属于上市公司股东的净利润3.22亿元，同比下降22.53%。公司营业收入分为医药工业和医药商业，前三季度公司医药商业收入保持增长，医药工业收入下降，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021140820a1e229fa&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"600976","symbol_name":"健民集团","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021140820a1e229fa&s=b","article_id":"2477500406","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021140820a1e229fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2477500406","pubTimestamp":1729490797,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"10月21日下午，健民集团举办2024年第三季度业绩说明会。会上有投资者询问，医药工业营收同比下降及毛利率下降是否为未来一段时间的趋势。净利润的下降除医药工业收入下降外，还有上年同期公司出售子公司股权带来的非经常性损益影响及中药材价格上涨带来的采购成本增加。毛利率下降的主要原因为工业收入的下降使得商业收入在整体收入的占比增加以及工业产品发出结构的变化所致。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"600976":"健民集团"},"translate_title":"Jianmin Group talks about the decline of net profit: the increase of procurement costs caused by the rising price of Chinese herbal medicines","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600976":1},"content_text":"10月21日下午，健民集团举办2024年第三季度业绩说明会。会上有投资者询问，医药工业营收同比下降及毛利率下降是否为未来一段时间的趋势。对此，健民集团财务总监程朝阳回复表示，2024年前三季度，公司实现营业收入28.81亿元，同比下降7.58%，实现归属于上市公司股东的净利润3.22亿元，同比下降22.53%。公司营业收入分为医药工业和医药商业，前三季度公司医药商业收入保持增长，医药工业收入下降，主要原因为本期公司营销转变考核模式、优化渠道库存带来的医药工业销售发出下降。净利润的下降除医药工业收入下降外，还有上年同期公司出售子公司股权带来的非经常性损益影响及中药材价格上涨带来的采购成本增加。毛利率下降的主要原因为工业收入的下降使得商业收入在整体收入的占比增加以及工业产品发出结构的变化所致。（上证路演）(编辑：林辰)关键字：医药","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2477500406"}